Shopping Cart (0)
My Account

Your Shopping Cart
Chemcon2014Prognostic, Predictive, and POC: Biomarkers from Research to ClinicFlow Chemistry IndiaMicrofluidics and Lab on a Chip IndiaDiagnostics & Biomarkers - Online Event20% Discount OfferePoster Award PrizeBlogs

MicroRNAs and Exosomes Market Report 2012

Publisher: Select Biosciences
Published: August 2012
Pages: 168

Price:



Disease Associations and Circulating Biomarkers


GEN Article

This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomes markets as they are evolving.  In this report, we focus upon the microRNA research marketplace from the perspective of the translational opportunities in these spaces.  The focus of this field is moving from basic research towards the utility of associations of microRNA expression patterns in disease.  In this manner, microRNA signatures may be validated as biomarkers in many disease areas—cancers, cardiovascular disease, neurological disease, inflammation, and metabolic diseases.

  • Select Biosciences has performed worldwide market tracking wherein we’ve analyzed end-user research trends in the microRNA as well as Exosome markets—these areas are evolving in parallel given the opportunity in the Circulating Biomarkers space and the utility of microRNAs and mRNAs to be harvested from exosomes and assayed as signatures for disease.
  • For exosomes, we’ve analyzed the research trends, types of downstream applications being performed as well as biomarker classes being studied currently and this is the First Market Report to Document the Market Landscape of Exosomes.

Select Biosciences has characterized the associations of microRNAs in various disease classes and presents these detailed associations as “hotspot maps” in this report.  Specifically, these associations [to be interpreted as starting material for biomarker development and validation] are described for many cancer classes, cardiovascular disease, CNS disease, diabetes, inflammation, and obesity.  They offer the opportunity for R&D planning efforts addressing the question of “which microRNA content needs to be addressed in a particular disease class.”

This data-driven characterization of the microRNAs and Exosomes landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans—this Market Report is written and delivered to customers in PowerPoint format.

Extensive Technical and Market Analyses
Presented in this Report

  • MicroRNA Research Market Analysis
    • Research Market Size and Growth Rate
    • Grant Funding Metrics
    • Qualitative and Quantitative Research Market Trends
      • Segmentation of Research Activities
      • Market Penetrance of Product Vendors into the microRNA Research Market
      • Unmet Needs
  • Association of microRNA Expression Patterns in Various Disease Classes
    • Various Types of Cancer: Breast Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, GI Tract Cancers, Hematological Malignancies
    • Muscular Development and Cardiovascular Disease
    • CNS Disease
    • Metabolic Disease, Diabetes
    • Stem Cells
    • Liver Disease, Liver Toxicity
  • Exosomes Marketplace
    • Nature and Categorization
    • Current Research Trends based on Primary Market Survey
    • Downstream Applications
  • Circulating Biomarkers
    • Utility of microRNA Signatures
    • microRNA Signatures in Specific Cancers Characterized in Biological Fluids to Date

Report Table of Contents (TOC) [Click Here to Download PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
Bioimaging Asia - Biological Imaging - Call for papers
Bioimaging Asia - Biological Imaging - Call for papers
Bioimaging Asia is taking place the 24-25 September 2015 in Singapore. Submit your abstract for consideration now.


International Bioprinting Congress 2014 - Testimonial
Dr. Mark DeCoster, Associate Professor, Biomedical Engineering, Louisiana Tech University, USA Hot, important growing area and Select Biosciences is helping to lead the way. The panel discussions were especially innovative.


Call for papers - Clinical Applications of Stem Cells 2015
Call for papers - Clinical Applications of Stem Cells 2015
We are now accepting papers for the Clinical Applications of Stem Cells meeting which will take place on the 26-27 of February 2015 in Singapore.


International Bioprinting Congress 2014 - Testimonial
Professor Chua Chee Kai, Director NTU Additive Manufacturing Centre, Singapore. From a Co-Chair perspective, I am very pleased, the meeting was well organised and covered all aspects of the subject, from the scientific techniques through to intellectual property, moving forward in to the next advancements we can expect to see in the field. I am already looking forward to next year’s meeting.


International Bioprinting Congress 2014 - Testimonial
Dr. Vladimir Mironov, Visiting Professor, Centre for Information Technology Renato Archer, Brazil. The most exciting conference I have ever attended. Very inspiring and very well organised.


Keynote Speaker Confirmed, Stephen Minger
We are thrilled to announce that Stephen Minger, Global Director of GE Healthcare, has confirmed he will be giving a keynote presentation at Stem Cells in Drug Discovery 2015.

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com